Gene · 642
BLMH: bleomycin hydrolase
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. BLMH: bleomycin hydrolase. Genes, record 642. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/642
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q13867 | Bleomycin hydrolase | 455 | 6 | Ensembl, GeneID, HGNC |
Source UniProt
Patents21
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 39036 | Q13867 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 1942 | Q13867 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 1942 | Q13867 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 9196 | Q13867 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 9196 | Q13867 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 112167 | Q13867 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 1169 | Q13867 | Espacenet |
| US 11041865 B2 | 2021-06-22 | 1176 | Q13867 | Espacenet |
| US 10613090 B2 | 2020-04-07 | 55 | Q13867 | Espacenet |
| JP 2019054813 A | 2019-04-11 | 219471 | Q13867 | Espacenet |
1 to 10 of 21
See all 21 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,117
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | BLMH papers | Newest fiscal year |
|---|---|---|---|
| R01GM082946 | AAV capsids and their cellular interactions | 7 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| P30AI050409 | Center for AIDS Research at Emory University | 4 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| R01AG011085 | Ubiquitin‐mediated proteolysis and cell cycle control | 3 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 3 | 2025 |
| P01AG041710 | Health, Aging and Dementia in South Africa: A Longitudinal Study (HAALSI) | 2 | 2025 |
| P30AI027757 | University of Washington/Fred Hutch Center for AIDS Research | 2 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 2 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 1,117Source NIH's project files
See all 1,117 nih grantsPapers2,639
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative Multi-Omics Mendelian Randomization Identifies BLMH as a Keratinocyte-Enriched Protective Candidate Gene and Potential Therapeutic Target in Psoriasis. | J Inflamm Res | 2026 | 42634679 | PubTator, text mining | PubMed |
| Targeted proteomics of extreme vascular phenotypes in type 1 diabetes: the ESCAPER study. | Cardiovasc Diabetol | 2026 | 42323624 | PubTator, text mining | PubMed |
| Adaptive Coordination Engineering for Efficient and Robust H2 Release. | Adv Sci (Weinh) | 2026 | 42272434 | PubTator, text mining | PubMed |
| Ruling Out E/Z Isomerization in the Inverted Solvatochromism of Brooker's Merocyanine. | J Phys Chem Lett | 2026 | 42148508 | PubTator, text mining | PubMed |
| Helicity of the bridge helix of Cas12a regulates on-target DNA cleavage efficiency and off-target cleavage propensity. | Biochem Biophys Res Commun | 2026 | 42143446 | PubTator, text mining | PubMed |
| From early-onset asthma to chronic obstructive pulmonary disease: potential mediating proteins and therapeutic targets. | Brief Bioinform | 2026 | 42089751 | PubTator, text mining | PubMed |
| Site-Selective B─H Activation via HAT Toward Xanthyl-closo-Carboranes as Bench-Stable Precursors of Organosulfur Boron Clusters. | Angew Chem Int Ed Engl | 2026 | 42021128 | PubTator, text mining | PubMed |
| Modification of internal RNA domains from the long non-coding RNA XIST refines roles in silencing and heterochromatin recruitment. | Hum Mol Genet | 2026 | 41926242 | PubTator, text mining | PubMed |
| Migration at Boron Cage for Selective B-H Functionalization of nido-Carboranes. | Angew Chem Int Ed Engl | 2026 | 41906955 | PubTator, text mining | PubMed |
| Proteomic Insights into Venous Thromboembolism. | Med Sci (Basel) | 2026 | 41718141 | PubTator, text mining | PubMed |
1 to 10 of 2,639
See all 2,639 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/642
GET https://conductscience.org/api/genes/v1/642/patents?page=2